Omega‑3 polyunsaturated fatty acids (PUFA) play a vital role in the healthy development and functioning of the brain and central nervous system in infants and children. Docosahexaenoic acid [DHA, 22:6(n‑3)] is the most abundant omega‑3 PUFA in the human brain, and it supports the normal development of the brain, eyes, and nerves. Eicosapentaenoic acid [EPA, 20:5(n‑3)] is the major precursor for eicosanoid metabolism, and it regulates neuronal and immune processes by influencing gene expression. Numerous human observational and clinical trials support a link between childhood neurodevelopmental and immune disorders with a deficiency of dietary EPA and DHA, as well as omega‑6:omega‑3 PUFA imbalances. Currently, <10% of children meet recommended intakes of EPA+DHA. Therefore, supplementation of DHA as well as EPA is critical to support optimal neurocognitive, neurobehavioural, and immune function throughout childhood.
Each chewable softgel contains:
Fish oil 420 mg
Providing Eicosapentaenoic acid (EPA) [EPA; 20:5(n-3)] 137.5 mg
Docosahexaenoic acid (DHA) [DHA; 22:6(n-3)] 56.25 mg
From wild deep-sea fish oil: sardine (Sardina pilchardus) and anchovy (Engraulis engrasicolus).
Pharmaceutical grade. Molecularly distilled or CO2-extracted.
Non-medicinal Ingredients: Non‑GMO D‑alpha‑tocopherol (from sunflower); annatto extract; turmeric (Curcuma longa) root extract; Stevia rebaudiana extract; and natural lemon, orange, and blackcurrant flavour; in a softgel made of glycerin, bovine gelatin (BSE‑free), potato starch, sunflower lecithin, and purified water.
Children 3-18 years old: Chew 1 softgel four times daily or as directed by your health-care practitioner.
Gluten, soy, wheat, corn, eggs, dairy, yeast, preservatives, artificial flavour or colour, or sugar.